Phase II trial of combination pembrolizumab, olaparib, and temozolomide for patients with recurrent glioma

被引：0
|
作者：
Schaff, Lauren [1 ]
Fortunato, John [1 ]
Grommes, Christian [1 ]
Gavrilovic, Igor T. [1 ]
Lin, Andrew [1 ]
Pentsova, Elena [1 ]
Miller, Alex [1 ]
Newton, Adam [1 ]
Gonzalez, Ashley [1 ]
Mellinghoff, Ingo K. [1 ]
Kaley, Thomas Joseph [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2087
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II clinical trial of olaparib plus pembrolizumab in the treatment of patients with advanced biliary tract cancer
    O'Bryan, James
    Yin, Chao
    Weinberg, Benjamin Adam
    Noel, Marcus Smith
    Mukherji, Reetu
    Kulasekaran, Monika
    Agarwal, Seema
    Kupfer, Gary
    Wang, Hongkun
    Hartley, Marion L.
    Marshall, John
    He, Aiwu Ruth
    Asco Authors Grp
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma
    Sathornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James J.
    McLendon, Roger E.
    Marcello, Jennifer
    Herndon, James E.
    Mathe, Alyssa
    Hamilton, Marta
    Rich, Jeremy N.
    Norfleet, Julie A.
    Gururangan, Sridharan
    Friedman, Henry S.
    Reardon, David A.
    NEURO-ONCOLOGY, 2010, 12 (12) : 1300 - 1310
  • [33] Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
    Perry, James R.
    Belanger, Karl
    Mason, Warren P.
    Fulton, Dorcas
    Kavan, Petr
    Easaw, Jacob
    Shields, Claude
    Kirby, Sarah
    Macdonald, David R.
    Eisenstat, David D.
    Thiessen, Brian
    Forsyth, Peter
    Pouliot, Jean-Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (12) : 2051 - 2057
  • [34] A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB IN COMBINATION WITH OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA
    Arrillaga-Romany, Isabel
    Sahebjam, Solmaz
    Picconi, David
    Campian, Jian
    Giglio, Pierre
    Drappatz, Jan
    Aiken, Robert
    Villano, John
    Lee, Eudocia
    Welch, Mary
    Ellingson, Benjamin
    Ney, Douglas
    Becker, Kevin
    Muzikansky, Alona
    Das, Biswajit
    Swisher, Elizabeth
    Nixon, Andrew
    Karlovich, Chris
    Williams, P. Mickey
    Ivy, S. Percy
    Batchelor, Tracy
    Gerstner, Elizabeth
    NEURO-ONCOLOGY, 2019, 21 : 27 - 27
  • [35] Results of stage 1 of the oparatic trial: A phase I study of olaparib in combination with temozolomide in patients with relapsed glioblastoma
    Chalmers, Anthony J.
    Jackson, Alan
    Swaisland, Helen
    Stewart, William
    Helford, Sarah E. R.
    Mollfe, L. Rhoda
    Hargrave, Darren R.
    McCormick, Alex
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma
    Sepulveda, J. M.
    Belda-Iniesta, C.
    Gil-Gil, M.
    Perez-Segura, P.
    Berrocal, A.
    Reynes, G.
    Gallego, O.
    Capellades, J.
    Ordonez, J. M.
    La Orden, B.
    Balana, C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (09): : 743 - 750
  • [37] A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma
    J. M. Sepúlveda
    C. Belda-Iniesta
    M. Gil-Gil
    P. Pérez-Segura
    A. Berrocal
    G. Reynés
    O. Gallego
    J. Capellades
    J. M. Ordoñez
    B. La Orden
    C. Balañá
    Clinical and Translational Oncology, 2015, 17 : 743 - 750
  • [38] Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial
    Hanna, Catherine
    Kurian, Kathreena M.
    Williams, Karin
    Watts, Colin
    Jackson, Alan
    Carruthers, Ross
    Strathdee, Karen
    Cruickshank, Garth
    Dunn, Laurence
    Erridge, Sara
    Godfrey, Lisa
    Jefferies, Sarah
    McBain, Catherine
    Sleigh, Rebecca
    McCormick, Alex
    Pittman, Marc
    Halford, Sarah
    Chalmers, Anthony J.
    NEURO-ONCOLOGY, 2020, 22 (12) : 1840 - 1850
  • [39] Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma
    Reardon, DA
    Quinn, JA
    Rich, JN
    Desjardins, A
    Vredenburgh, J
    Gururangan, S
    Sathornsumetee, S
    Badruddoja, M
    McLendon, R
    Provenzale, J
    Herndon, JE
    Dowell, JM
    Burkart, JL
    Newton, HB
    Friedman, AH
    Friedman, HS
    CANCER, 2005, 104 (07) : 1478 - 1486
  • [40] VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL
    Peters, Katherine B.
    Reardon, David A.
    Vredenburgh, James J.
    Desjardins, Annick
    Herndon, James E., II
    Coan, April
    McSherry, Frances
    Lipp, Eric
    Brickhouse, Alise
    Massey, Woody
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2012, 14 : 81 - 81
12345